This study analyzes the impact of treatment with GLP-1 RAs on glycemic values, HbA1c, weight, insulin resistance, and other cardio-reno-metabolic risk factors in patients with T2D and offers insights regarding a less-studied specific population, namely Romanian individuals (Central–Eastern European population) with this metabolic condition. This evidence concerns the gene GCG and type 2 diabetes mellitus.